Humana Inc. (NYSE:HUM) Shares Sold by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. decreased its position in Humana Inc. (NYSE:HUM) by 10.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 72,809 shares of the insurance provider’s stock after selling 8,385 shares during the period. PNC Financial Services Group Inc. owned about 0.06% of Humana worth $18,472,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. FMR LLC increased its stake in shares of Humana by 23.4% in the 3rd quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock worth $1,073,387,000 after acquiring an additional 643,291 shares during the last quarter. Thrivent Financial for Lutherans raised its position in shares of Humana by 55.6% during the 3rd quarter. Thrivent Financial for Lutherans now owns 600,317 shares of the insurance provider’s stock worth $190,145,000 after acquiring an additional 214,535 shares in the last quarter. Retirement Systems of Alabama boosted its position in shares of Humana by 735.9% in the 4th quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock valued at $55,563,000 after purchasing an additional 192,801 shares during the period. Pzena Investment Management LLC increased its stake in Humana by 8.1% in the third quarter. Pzena Investment Management LLC now owns 2,506,250 shares of the insurance provider’s stock valued at $793,830,000 after purchasing an additional 187,903 shares during the period. Finally, Worldquant Millennium Advisors LLC acquired a new position in shares of Humana in the third quarter valued at approximately $50,102,000. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Price Performance

HUM opened at $251.41 on Tuesday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $406.46. The stock has a fifty day moving average price of $271.74 and a 200 day moving average price of $282.37. The stock has a market cap of $30.33 billion, a price-to-earnings ratio of 25.27, a PEG ratio of 2.05 and a beta of 0.57.

Humana (NYSE:HUM) last announced its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.41%. Humana’s dividend payout ratio is currently 35.58%.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the stock. Barclays raised their target price on shares of Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a report on Thursday, February 13th. Royal Bank of Canada restated an “outperform” rating and set a $283.00 price objective on shares of Humana in a report on Wednesday, February 12th. Truist Financial boosted their price objective on shares of Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research note on Monday, January 6th. Morgan Stanley lowered their target price on Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a research note on Wednesday, February 12th. Finally, StockNews.com lowered Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, March 5th. Twenty equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, Humana currently has an average rating of “Hold” and an average target price of $285.68.

Insider Activity at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.32% of the stock is owned by company insiders.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.